Increased CX3CL1 mRNA Expression Level Is a Positive Prognostic Factor in Patients With Lung Adenocarcinoma

Oncology Letters - Greece
doi 10.3892/ol.2019.10211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Pretreatment Hemoglobin Level Is an Independent Prognostic Factor in Patients With Lung Adenocarcinoma

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Met Expression Is an Independent Prognostic Risk Factor in Patients With Oesophageal Adenocarcinoma

British Journal of Cancer
Cancer ResearchOncology
2008English

High Expression of SLC34A2 Is a Favorable Prognostic Marker in Lung Adenocarcinoma Patients

Tumor Biology
MedicineCancer Research
2017English

Increased KIF4A Expression Is a Potential Prognostic Factor in Prostate Cancer

Oncology Letters
Cancer ResearchOncology
2018English

A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Expression of Ribophorine II Is a Promising Prognostic Factor in Human Gastric Adenocarcinoma

International Journal of Oncology
Cancer ResearchOncology
2016English

ERRα Is an Aggressive Factor in Lung Adenocarcinoma Indicating Poor Prognostic Outcomes

Cancer Management and Research
Oncology
2019English

P3.04-06 Prognostic Significance of Serum CXCL12 Level in Patients With Surgical Resected Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Serum KL‐6 Level Is a Prognostic Marker in Patients With Anti‐MDA5 Antibody‐positive Dermatomyositis Associated With Interstitial Lung Disease

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy